C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/14 (2006.01) A61K 31/439 (2006.01) A61K 31/551 (2006.01) C07D 487/14 (2006.01)
Patent
CA 2657623
The present invention is directed to bridged diazepan compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
La présente invention concerne des composés de diazépan pontés qui sont des antagonistes des récepteurs de l'oréxine et que l'on peut utiliser pour le traitement ou la prévention de troubles ou de maladies neurologiques ou psychiatriques dans lesquels les récepteurs de l'oréxine sont impliqués. L'invention concerne également des compositions pharmaceutiques comprenant ces composés et l'utilisation de ces composés et de ces compositions pour la prévention ou le traitement des maladies dans lesquelles les récepteurs de l'oréxine sont impliqués.
Coleman Paul J.
Cox Christopher D.
Mcgaughey Georgia B.
Roecker Anthony J.
Schreier John D.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Bridged diazepan orexin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bridged diazepan orexin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bridged diazepan orexin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1620414